Genpharm is a private pharmaceutical company founded in 2012 and based in the Dubai Science Park (DSP), U.A.E. We are the leading partner for Rare Diseases and Speciality companies for the Middle East and Turkey. We provide our partners with fast track market access and sustainable go-to market and tailored commercial strategies. Our core activities are focused on disease awareness, early patient diagnosis, as well as, scientific, medical and CME events. We work closely with the key scientific societies and the key stakeholders. We are the first organization to successfully introduce gene and cell therapy in the Region. Our current partners are Novartis Gene Therapies, Orchard Therapeutics, PTC, Amicus, Sarepta, Ultragenyx, Albireo, Quoin, Argenx and others. We operate through the highest ethical standards and have been audited by all of our partners for Compliance, Quality and PV.